Intraperitoneal carboplatin infusion may be a pharmacologically more reasonable route than intravenous administration as a systemic chemotherapy. A comparative pharmacokinetic analysis of platinum using a new mathematical model after intraperitoneal vs. intravenous infusion of carboplatin—A Sankai Gynecology Study Group (SGSG) study
Authors:
- Y MiyagiYMY Miyagi
- K FujiwaraKFK Fujiwara
- J KigawaJKJ Kigawa
- H ItamochiHIH Itamochi
- S NagaoSNS Nagao
- E AotaniEAE Aotani
- N TerakawaNTN Terakawa
- I KohnoIKI Kohno
- 1 December 2005
- journal article
- clinical trial
- Published by Elsevier in Gynecologic Oncology
- Vol. 99 (3) , 591-596